Evidence map›Paper›PMID 27911780›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Selective sweep suggests transcriptional regulation may underlie Plasmodium vivax resilience to malaria control measures in Cambodia.

Christian M Parobek, Jessica T Lin, David L Saunders, Eric J Barnett, Chanthap Lon, Charlotte A Lanteri, Sujata Balasubramanian, Nicholas Brazeau, Derrick K DeConti, Deen L Garba and 5 more

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Article
  3. Rare variation in malaria parasites biases population-genetic inference.bioRxiv : the preprint server for biology · 2026
    Article
  4. Towards an evolutionary baseline model ofbioRxiv : the preprint server for biology · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. No Association between the Plasmodium vivaxAntimicrobial agents and chemotherapy · 2023
    Article
  15. Declines in prevalence alter the optimal level of sexual investment for the malaria parasiteProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  16. Review
  17. Review
  18. An open dataset ofWellcome open research · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 3 countries.

Christian M ParobekCurriculum in Genetics and Molecular Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.
Jessica T LinDivision of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.
David L SaundersUS Army Medical Component, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand 10400.
Eric J BarnettUpstate Medical University, State University of New York, Syracuse, NY 13210.
Chanthap LonUS Army Medical Component, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand 10400.
Charlotte A LanteriUS Army Medical Component, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand 10400.
Sujata BalasubramanianDivision of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.
Nicholas BrazeauDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.
Derrick K DeContiProgram in Bioinformatics and Integrative Biology, University of Massachusetts School of Medicine, Worcester, MA 01655.
Deen L GarbaDivision of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.
Steven R MeshnickDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.
Michele D SpringUS Army Medical Component, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand 10400.
Char Meng ChuorNational Center for Parasitology, Entomology and Malaria Control, Phnom Penh, Cambodia.
Jeffrey A BaileyProgram in Bioinformatics and Integrative Biology, University of Massachusetts School of Medicine, Worcester, MA 01655.
Jonathan J JulianoCurriculum in Genetics and Molecular Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599; jjuliano@med.unc.edu.
University of North Carolina at Chapel Hill · USArmed Forces Research Institute of Medical Science · THCambodia National Malaria Center · KHUniversity of Massachusetts Chan Medical School · USSUNY Upstate Medical University · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM008719 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DARVILLE, TONI, DESHMUKH, MOHANISH P · 1999 to 2023
$15.1M
NRSA IN GENETICST32GM007092 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SEKELSKY, JEFF J. · 1985 to 2019
$5.9M
Human copy number polymorphism and severe malariaR01AI099473 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI BAILEY, JEFFREY A. · 2012 to 2015
$2.3M
Within Host Selection of P. falciparum Variants by Artemisinin Combination TherapR01AI089819 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI JULIANO, JONATHAN J · 2010 to 2014
$1.9M
Genetic determinants of Plasmodium vivax relapseK08AI110651 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LIN, JESSICA · 2014 to 2018
$869k
Dissecting Chloroquine Resistance in the Plasmodium vivax CrossR21AI111108 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI JULIANO, JONATHAN J · 2014 to 2015
$442k
Investigating the targets and strain specificity of antibodies against P. vivaxF30AI109979 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI PAROBEK, CHRISTIAN · 2015 to 2017
$108k
NIAID NIH HHS F30 AI109979NIAID NIH HHS K08 AI110651NIAID NIH HHS R01 AI089819NIAID NIH HHS R01 AI099473NIAID NIH HHS R21 AI111108NIGMS NIH HHS T32 GM007092NIGMS NIH HHS T32 GM008719
6 · The paper itself

Abstract

Cambodia, in which both Plasmodium vivax and Plasmodium falciparum are endemic, has been the focus of numerous malaria-control interventions, resulting in a marked decline in overall malaria incidence. Despite this decline, the number of P vivax cases has actually increased. To understand better the factors underlying this resilience, we compared the genetic responses of the two species to recent selective pressures. We sequenced and studied the genomes of 70 P vivax and 80 P falciparum isolates collected between 2009 and 2013. We found that although P falciparum has undergone population fracturing, the coendemic P vivax population has grown undisrupted, resulting in a larger effective population size, no discernable population structure, and frequent multiclonal infections. Signatures of selection suggest recent, species-specific evolutionary differences. Particularly, in contrast to P falciparum, P vivax transcription factors, chromatin modifiers, and histone deacetylases have undergone strong directional selection, including a particularly strong selective sweep at an AP2 transcription factor. Together, our findings point to different population-level adaptive mechanisms used by P vivax and P falciparum parasites. Although population substructuring in P falciparum has resulted in clonal outgrowths of resistant parasites, P vivax may use a nuanced transcriptional regulatory approach to population maintenance, enabling it to preserve a larger, more diverse population better suited to facing selective threats. We conclude that transcriptional control may underlie P vivax's resilience to malaria control measures. Novel strategies to target such processes are likely required to eradicate P vivax and achieve malaria elimination.

Indexed as

CambodiaDNA Copy Number VariationsDNA, ProtozoanDrug ResistanceEndemic DiseasesGenetic VariationGenome, ProtozoanHaplotypesHumansMalaria, FalciparumMalaria, VivaxPlasmodium falciparumPlasmodium vivaxPolymorphism, Single NucleotideSelection, GeneticSpecies SpecificityDNA, ProtozoangenomemalariaPlasmodiumtranscriptionvivax

Identifiers

PMID27911780
PMCPMC5167194
OpenAlexW2559324192

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.